Study links sodium butyrate to better jejunal health in lambs

Bottom line

A new Frontiers in Veterinary Science study reports that adding 3 g/kg of coated sodium butyrate to the diets of early weaned lambs for 21 days improved several markers of jejunal health, including villus height, total antioxidant capacity, and mitochondrial structural integrity. The research team, led by Fangfang Zhao at Heilongjiang Bayi Agricultural University, compared 10 lambs weaned at 21 days of age in control and treatment groups, and found lower malondialdehyde and reactive oxygen species in jejunal tissue among supplemented lambs. Transcriptome data also suggested shifts in pathways tied to nutrient metabolism and immune function. The findings also fit with broader weaning-transition research in other species: in White King pigeons, coated sodium butyrate has been linked to higher feed intake at some inclusion levels, changes in inflammatory markers and serum proteins, improved jejunal villus height-to-crypt depth ratio, and microbiota shifts involving SCFA-producing taxa, although responses varied by dose. (frontiersin.org)

Why it matters: Early weaning is a high-risk period for oxidative stress, impaired gut development, and reduced feed efficiency in lambs, so a feed additive that appears to support intestinal morphology and cellular resilience could be relevant for flock health programs and nutrition planning. The cross-species signal is also notable, because coated sodium butyrate has shown weaning-related gut and performance effects in other young animals, but those studies also suggest dose matters and that not every response is uniformly beneficial. Still, this was a small lamb study, with just five animals per group, and the paper itself notes that the transcriptomic findings should be interpreted cautiously until larger trials confirm whether these tissue-level benefits translate into consistent gains in growth, health, or treatment reduction under field conditions. (frontiersin.org)

What to watch: Watch for larger commercial-scale lamb trials that test whether sodium butyrate’s gut and oxidative stress benefits hold up in real-world weaning programs, and whether future work helps define practical dose ranges, since results in other species suggest the response may not be linear. (frontiersin.org)

A June 23, 2026, paper in Frontiers in Veterinary Science adds new mechanistic evidence to the case for sodium butyrate in young ruminant diets. In early weaned lambs, researchers found that dietary sodium butyrate improved jejunal villus height, increased total antioxidant capacity, reduced oxidative stress markers, preserved mitochondrial ultrastructure, and altered gene expression linked to metabolism and immune regulation. (frontiersin.org)

The study builds on a growing body of work around butyrate as a gut-supportive feed additive during stressful transition periods. Weaning is a known pressure point in lamb production because animals are shifting from milk to solid feed while their intestine and microbiota are still developing. The authors note that this combination can trigger oxidative stress and mitochondrial dysfunction, which in turn can compromise nutrient absorption and immune health. Earlier work from the same research group, published in 2024, reported that coated sodium butyrate relieved weaning stress, improved average daily feed intake and average daily gain, and reshaped cecal and colonic microbiota in weaned lambs. (frontiersin.org)

In the new trial, the team enrolled 10 healthy lambs, 21 days old and averaging 6.53 kg, then randomly assigned them to a basal diet or the same diet plus 3 g/kg coated sodium butyrate for 21 days. Compared with controls, supplemented lambs had significantly greater jejunal villus height, higher total antioxidant capacity, lower malondialdehyde, reduced reactive oxygen species accumulation, and better-preserved mitochondrial morphology on ultrastructural examination. The transcriptome analysis indicated differential expression in pathways related to jejunal metabolism and immune function, and the dataset was deposited in NCBI BioProject 1131192. (frontiersin.org)

Those findings are directionally consistent with broader livestock literature. A recent review summarized evidence that butyrate supplementation can support gut barrier integrity, antioxidant status, feed efficiency, and growth performance across calves, piglets, poultry, and lambs, especially around weaning. Other species-specific work also points the same way, while underscoring that dose can shape the response. In White King pigeons during the weaning transition, coated sodium butyrate increased average daily feed intake at 0.1% and 0.2% inclusion, improved some immune and serum protein measures, increased the jejunal villus height-to-crypt depth ratio at 0.2%, and shifted the microbiota toward taxa including Oscillospiraceae and Muribaculaceae, which are associated with fiber fermentation and short-chain fatty acid production. But that pigeon study also found less favorable signals at higher inclusion levels, including increased TNF-α, IL-6, and D-lactic acid in the 0.4% group, reinforcing that “more” may not always be better. (pubmed.ncbi.nlm.nih.gov)

What’s missing is outside commentary and commercial validation. I did not find a separate institutional press release or published expert reaction specific to this June 2026 paper. That makes the study itself the main source of detail, and it also puts more weight on its limitations. Most notably, the experiment involved only five lambs per group, which limits statistical power and makes it hard to know how reproducible the transcriptomic signals will be across breeds, diets, housing systems, and health statuses. The authors explicitly say those gene-expression findings need validation in larger studies. (frontiersin.org)

Why it matters: For veterinary professionals advising sheep operations, this study strengthens the biological rationale for sodium butyrate as a non-antibiotic nutritional tool during early weaning, particularly where gut stress and inconsistent post-weaning performance are concerns. The mitochondrial and oxidative stress data are useful because they move beyond growth outcomes alone and suggest a potential mechanism for why some lambs may cope better with early dietary transition. The broader weaning literature, including the pigeon data, also suggests coated sodium butyrate can influence intake, intestinal architecture, inflammatory tone, and microbiota composition across species, but it highlights an important practical point: responses may be dose-dependent rather than uniformly positive. This is still pre-field evidence, not a practice-changing result on its own, and it doesn’t answer practical questions around formulation choice, economics, optimal timing, or how benefits compare with other gut-health strategies. (frontiersin.org)

What to watch: The next meaningful step will be larger, production-scale trials that pair tissue and transcriptomic endpoints with outcomes veterinarians and producers care about most, including morbidity, growth, feed conversion, and antimicrobial use. It will also be worth watching whether future studies clarify whether coated sodium butyrate works best as a short weaning-phase intervention or as part of a broader gut-health program before and after weaning, and whether species- and dose-specific response curves can be defined clearly enough to guide practical ration decisions. (frontiersin.org)

Common questions

  • What did the lamb study find about sodium butyrate?
    In 21-day-old early weaned lambs, 3 g/kg coated sodium butyrate for 21 days improved jejunal villus height, total antioxidant capacity, and mitochondrial structure, and it lowered malondialdehyde and reactive oxygen species in jejunal tissue.
  • How many lambs were in the study?
    The trial included 10 healthy lambs, with five animals per group.
  • What dose was used?
    The supplemented group received 3 g/kg coated sodium butyrate in the basal diet for 21 days.
  • How strong is this evidence for farm use?
    It is early evidence from a small study, and the paper says the transcriptomic findings need validation in larger trials before it is clear whether the tissue-level benefits translate to consistent gains in growth, health, or treatment reduction under field conditions.

Like what you're reading?

The Feed delivers veterinary news every weekday.